NCT01544764

Brief Summary

The North Carolina Immunization Branch will evaluate the use of the CDC program to improve adolescent vaccination practices (called Assessment, Feedback, Incentives, and eXchanges, or AFIX). This evaluation is the first of its kind in the nation and may have a profound impact on prevention. AFIX has four major components: 1) Assessment of a provider's current immunization practices and vaccination levels, 2) Feedback of the assessment results and strategies to improve coverage levels, 3) Incentives to improve coverage levels, and 4) eXchange of information and resources necessary to facilitate improvement. This program will evaluate the effectiveness of AFIX visits on affecting provider practices to increase adolescent (age 11-18) immunization. Visits include discussion of that practice's immunization rates and strategies for improving rates. The investigators will compare the changes, from baseline to 5 months, in immunization for practices receiving virtual visits (webinars), in-person visits, and no visits (control group). Thirty practices will be randomly assigned to each intervention type. The main outcomes of this study are practice-wide uptake rates of several adolescent vaccines (Tdap, HPV, and MCV4) as well as pre- and post-AFIX visit surveys focusing on recall tactics utilized by each practice. Data will be collected on practices with at least 200 adolescent patients (note: there is no patient-level data collected in this study).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
91

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2011

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2011

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

February 24, 2012

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 6, 2012

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

December 18, 2013

Status Verified

December 1, 2013

Enrollment Period

1.7 years

First QC Date

February 24, 2012

Last Update Submit

December 16, 2013

Conditions

Keywords

Diphtheria-Tetanus-Pertussis VaccineMeasles-Mumps-Rubella VaccineMeningococcal VaccinesHepatitis B VaccinesChickenpox VaccinePapillomavirus Vaccines

Outcome Measures

Primary Outcomes (1)

  • Change in Vaccination Rate: HPV vaccine initiation among 11-12 year olds

    We will gather practice-specific rates of coverage for adolescents (age 11-12) for the first dose of human papillomavirus (HPV) vaccine at baseline and 5 months follow-up.

    Baseline and 5 months follow-up

Secondary Outcomes (7)

  • Change in Vaccination Rate: HPV vaccine initiation among 13-18 year olds

    Baseline and 5 months follow-up

  • Change in Vaccination Rate: Tdap vaccine among 11-12 year olds

    Baseline and 5 months follow-up

  • Change in Vaccination Rate: Tdap vaccine among 13-18 year olds

    Baseline and 5 months follow-up

  • Change in Vaccination Rate: Meningitis vaccine among 11-12 year olds

    Baseline and 5 months follow-up

  • Change in Vaccination Rate: Meningitis vaccine among 13-18 year olds

    Baseline and 5 months follow-up

  • +2 more secondary outcomes

Other Outcomes (6)

  • Change in Vaccination Rate: MMR among 11-12 year olds

    Baseline and 5 months follow-up

  • Change in Vaccination Rate: MMR among 13-18 year olds

    Baseline and 5 months follow-up

  • Change in Vaccination Rate: Hepatitis B vaccine among 11-12 year olds

    Baseline and 5 months follow-up

  • +3 more other outcomes

Study Arms (3)

Control

NO INTERVENTION

This arm includes 30 health centers in North Carolina with at least 200 adolescent (age 11-18) patients. Practices in this arm were randomly assigned to receive no AFIX visit.

AFIX In-Person Visit

EXPERIMENTAL

This arm includes 30 health centers in North Carolina with at least 200 adolescent (age 11-18) patients. These practices received an in-person AFIX visit from a North Carolina Immunization Branch employee. Intervention: Other: Assessment , Feedback, Incentives, and eXchange Program

Other: Assessment , Feedback, Incentives, and eXchange Program

AFIX Webinar Visit

EXPERIMENTAL

This arm includes 31 health centers in North Carolina with at least 200 adolescent (age 11-18) patients. These practices received a webinar during which a North Carolina Immunization Branch employee completed the components of an AFIX visit. Intervention: Other: Assessment , Feedback, Incentives, and eXchange Program

Other: Assessment , Feedback, Incentives, and eXchange Program

Interventions

The NC Immunization Branch uses Adolescent AFIX (Assessment, Feedback, Incentives and eXchange) Program, a quality improvement strategy developed by the CDC to improve the immunization practices and vaccination coverage levels of public and private health care providers. It has four main components: 1) Assessment of a provider's current immunization practices and vaccination levels, 2) Feedback of the assessment results and strategies to improve coverage levels, 3) Incentives to improve coverage levels, and 4) eXchange of information and resources necessary to facilitate improvement.

AFIX In-Person VisitAFIX Webinar Visit

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Pediatric and/or family practices participating in the North Carolina Immunization Program
  • A minimum of 200 active adolescent patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Cervical Cancer-Free North Carolina

Chapel Hill, North Carolina, 27599, United States

Location

North Carolina Immunization Branch

Raleigh, North Carolina, 27699, United States

Location

Related Publications (2)

  • Gilkey MB, Dayton AM, Moss JL, Sparks AC, Grimshaw AH, Bowling JM, Brewer NT. Increasing provision of adolescent vaccines in primary care: a randomized controlled trial. Pediatrics. 2014 Aug;134(2):e346-53. doi: 10.1542/peds.2013-4257. Epub 2014 Jul 7.

  • Gilkey MB, Moss JL, Roberts AJ, Dayton AM, Grimshaw AH, Brewer NT. Comparing in-person and webinar delivery of an immunization quality improvement program: a process evaluation of the adolescent AFIX trial. Implement Sci. 2014 Feb 18;9:21. doi: 10.1186/1748-5908-9-21.

MeSH Terms

Conditions

Hepatitis B

Interventions

Restraint, Physical

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsHepadnaviridae InfectionsDNA Virus InfectionsVirus DiseasesHepatitis, Viral, HumanHepatitisLiver DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Behavior ControlTherapeuticsImmobilizationInvestigative Techniques

Study Officials

  • Amanda Dayton, MA

    DPH/WCH/Immunization

    PRINCIPAL INVESTIGATOR
  • Amy Grimshaw, MS, MSW

    DPH/WCH/Immunization

    PRINCIPAL INVESTIGATOR
  • Noel T Brewer, PhD

    University of North Carolina, Chapel Hill

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 24, 2012

First Posted

March 6, 2012

Study Start

April 1, 2011

Primary Completion

December 1, 2012

Study Completion

December 1, 2012

Last Updated

December 18, 2013

Record last verified: 2013-12

Locations